Trial Profile
Intermittent Treatment with Taxotere and Prednisone in patients with asymptomatic, hormone-refractory prostate cancer: A Multicenter Phase II Trial.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Aug 2015
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary) ; Prednisolone (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Acronyms TOPAS
- 29 Aug 2011 New trial record